{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:07:22Z","timestamp":1791472042709,"version":"4.3.4"},"reference-count":208,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1124\/pharmrev.121.000400","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T16:15:51Z","timestamp":1641399351000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease"],"prefix":"10.1016","volume":"74","author":[{"given":"Vincent","family":"Pons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rivest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pharmrev.121.000400_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1176\/ajp.153.2.243","article-title":"Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer\u2019s disease","volume":"153","author":"Aarsland","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pharmrev.121.000400_bib3","doi-asserted-by":"crossref","first-page":"n156","DOI":"10.1136\/bmj.n156","article-title":"Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis","volume":"372","author":"Ackley","year":"2021","journal-title":"BMJ"},{"key":"10.1124\/pharmrev.121.000400_bib4","series-title":"From Innate Immunity to Immunological Memory","first-page":"1","article-title":"TLR Signaling,","author":"Akira","year":"2006"},{"key":"10.1124\/pharmrev.121.000400_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/08830185.2014.902453","article-title":"Transcriptomic network support distinct roles of classical and non-classical monocytes in human","volume":"33","author":"Anbazhagan","year":"2014","journal-title":"Int Rev Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alz.12192","article-title":"Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease","volume":"17","author":"Arnsten","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1124\/pharmrev.121.000400_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/rtph.2002.1541","article-title":"Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant","volume":"35","author":"Baldrick","year":"2002","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1124\/pharmrev.121.000400_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","article-title":"Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer\u2019s disease","volume":"60","author":"Balducci","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1124\/pharmrev.121.000400_bib9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer\u2019s disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/pharmrev.121.000400_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.neurobiolaging.2013.11.006","article-title":"Age and duration of inflammatory environment differentially affect the neuroimmune response and catecholaminergic neurons in the midbrain and brainstem","volume":"35","author":"Bardou","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1124\/pharmrev.121.000400_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00702-017-1795-7","article-title":"Differential contribution of microglia and monocytes in neurodegenerative diseases","volume":"125","author":"Baufeld","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1124\/pharmrev.121.000400_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"10.1124\/pharmrev.121.000400_bib13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2012-121060","article-title":"The Imbalance of Vascular Molecules in Alzheimer\u2019s Disease","volume":"32","author":"Bell","year":"2012","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1124\/pharmrev.121.000400_bib14","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00429-014-0759-z","article-title":"Patrolling monocytes play a critical role in CX3CR1-mediated neuroprotection during excitotoxicity","volume":"220","author":"Bellavance","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1124\/pharmrev.121.000400_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12974-018-1348-5","article-title":"Partial reduction of microglia does not affect tau pathology in aged mice","volume":"15","author":"Bennett","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.121.000400_bib16","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1093\/hmg\/ddh077","article-title":"Alzheimer\u2019s disease: one disorder, too many genes?","volume":"13","author":"Bertram","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pharmrev.121.000400_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-11-25","article-title":"Modulation of inflammation in transgenic models of Alzheimer\u2019s disease","volume":"11","author":"Birch","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.121.000400_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1124\/pharmrev.121.000400_bib19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuron.2017.04.043","article-title":"Diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures","volume":"94","author":"Bohlen","year":"2017","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.121.000400_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/brain\/awn331","article-title":"Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer\u2019s disease","volume":"132","author":"Boissonneault","year":"2009","journal-title":"Brain"},{"key":"10.1124\/pharmrev.121.000400_bib21","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1523\/JNEUROSCI.22-08-03234.2002","article-title":"Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis","volume":"22","author":"Boncristiano","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41598-017-18433-4","article-title":"IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential","volume":"8","author":"Boulakirba","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000400_bib23","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","article-title":"Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes","volume":"36","author":"Brenowitz","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1124\/pharmrev.121.000400_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1212\/WNL.0000000000002387","article-title":"Higher brain BDNF gene expression is associated with slower cognitive decline in older adults","volume":"86","author":"Buchman","year":"2016","journal-title":"Neurology"},{"key":"10.1124\/pharmrev.121.000400_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1567205014666170829100100","article-title":"Modulation of inflammation as a way of delaying Alzheimer\u2019s disease progression: the diet\u2019s role","volume":"15","author":"Businaro","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.1124\/pharmrev.121.000400_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15327","article-title":"Microglial phagocytosis of neurons in neurodegeneration, and its regulation","author":"Butler","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"10.1124\/pharmrev.121.000400_bib27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib29","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","article-title":"Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid","volume":"96","author":"Calhoun","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib30","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.3389\/fimmu.2020.01588","article-title":"Role of toll like receptor 4 in Alzheimer\u2019s disease","volume":"11","author":"Calvo-Rodriguez","year":"2020","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/nan.12042","article-title":"Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy","volume":"39","author":"Carare","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1124\/pharmrev.121.000400_bib32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cell.2013.03.010","article-title":"Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal","volume":"153","author":"Carlin","year":"2013","journal-title":"Cell"},{"key":"10.1124\/pharmrev.121.000400_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuron.2014.11.020","article-title":"IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior","volume":"85","author":"Chakrabarty","year":"2015","journal-title":"Neuron"},{"key":"10.1124\/pharmrev.121.000400_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517709278","article-title":"Tumor necrosis factor \u03b1 inhibition for Alzheimer\u2019s disease","volume":"9","author":"Chang","year":"2017","journal-title":"J Cent Nerv Syst Dis"},{"issue":"9","key":"10.1124\/pharmrev.121.000400_bib35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: Structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1124\/pharmrev.121.000400_bib36","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1124\/pharmrev.121.000400_bib37","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/cdd.2010.60","article-title":"IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation","volume":"17","author":"Chihara","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1124\/pharmrev.121.000400_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tins.2016.03.005","article-title":"Emerging roles for CSF-1 receptor and its ligands in the nervous system","volume":"39","author":"Chitu","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2005.11.006","article-title":"Colony-stimulating factor-1 in immunity and inflammation","volume":"18","author":"Chitu","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib40","doi-asserted-by":"crossref","first-page":"32301","DOI":"10.1074\/jbc.274.45.32301","article-title":"Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer\u2019s amyloid \u03b2-peptide by microglial cells","volume":"274","author":"Chung","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.121.000400_bib41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbi.2017.12.007","article-title":"Scavenger Receptor-A deficiency impairs immune response of microglia and astrocytes potentiating Alzheimer\u2019s disease pathophysiology","volume":"69","author":"Cornejo","year":"2018","journal-title":"Brain Behav Immun"},{"issue":"5","key":"10.1124\/pharmrev.121.000400_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036734","article-title":"\u201cMuramyl dipeptide induces NOD2-dependent Ly6Chigh monocyte recruitment to the lungs and protects against influenza virus infection.\u201d Edited by Dario S. Zamboni","volume":"7","author":"Coulombe","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1124\/pharmrev.121.000400_bib43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3233\/JAD-160625","article-title":"Changes in plasma \u03b2-NGF and its receptors expression on peripheral blood monocytes during Alzheimer\u2019s disease progression","volume":"55","author":"Crispoltoni","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.121.000400_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1124\/pharmrev.121.000400_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41593-018-0329-4","article-title":"Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer\u2019s disease mouse models","volume":"22","author":"Cruz Hern\u00e1ndez","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib46","series-title":"Early Origin and Colonization of the Developing Central Nervous System by Microglial Precursors, (Progress in Brain Research), Vol. 132","first-page":"51","author":"Cuadros","year":"2001"},{"key":"10.1124\/pharmrev.121.000400_bib47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ni973","article-title":"Regulation of macrophage and neutrophil cell fates by the PU.1:C\/EBPalpha ratio and granulocyte colony-stimulating factor","volume":"4","author":"Dahl","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib48","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1073\/pnas.93.7.2996","article-title":"Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein","volume":"93","author":"Davis","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/cam.2.2.6374","article-title":"LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells","volume":"2","author":"Dedieu","year":"2008","journal-title":"Cell Adhes Migr"},{"key":"10.1124\/pharmrev.121.000400_bib50","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012889","article-title":"Attenuated CSF-1R signalling drives cerebrovascular pathology","volume":"13","author":"Delaney","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1124\/pharmrev.121.000400_bib51","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease","volume":"369","author":"Doody","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000400_bib53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1084\/jem.20031237","article-title":"Toll-like receptors induce a phagocytic gene program through p38","volume":"199","author":"Doyle","year":"2004","journal-title":"J Exp Med"},{"key":"10.1124\/pharmrev.121.000400_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1124\/pharmrev.121.000400_bib55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4049\/jimmunol.1402330","article-title":"Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice","volume":"194","author":"Dugan","year":"2015","journal-title":"J Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.121.000400_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphys.2013.00045","article-title":"The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease","volume":"4","author":"Elali","year":"2013","journal-title":"Front Physiol"},{"issue":"7","key":"10.1124\/pharmrev.121.000400_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200251","article-title":"Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls","volume":"13","author":"Esparza","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1124\/pharmrev.121.000400_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jchemneu.2019.02.002","article-title":"Up-regulation of TREM2 accelerates the reduction of amyloid deposits and promotes neuronal regeneration in the hippocampus of amyloid beta1-42 injected mice","volume":"97","author":"Fan","year":"2019","journal-title":"J Chem Neuroanat"},{"key":"10.1124\/pharmrev.121.000400_bib60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12974-020-01893-3","article-title":"Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer\u2019s disease","volume":"17","author":"Fani Maleki","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.121.000400_bib61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic System","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/pharmrev.121.000400_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fncel.2018.00329","article-title":"Role of microglia TLRs in neurodegeneration","volume":"12","author":"Fiebich","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib63","doi-asserted-by":"crossref","first-page":"E5172","DOI":"10.1073\/pnas.1606253113","article-title":"Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus","volume":"113","author":"Finsterbusch","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib64","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neurobiolaging.2018.04.004","article-title":"Sexual dimorphism in predisposition to Alzheimer\u2019s disease","volume":"70","author":"Fisher","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1124\/pharmrev.121.000400_bib65","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1038\/sj.onc.1210764","article-title":"Transcriptional control of granulocyte and monocyte development","volume":"26","author":"Friedman","year":"2007","journal-title":"Oncogene"},{"key":"10.1124\/pharmrev.121.000400_bib66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnagi.2019.00020","article-title":"Revisiting the role of insulin-like growth factor-I receptor stimulating activity and the apolipoprotein E in Alzheimer\u2019s disease","volume":"11","author":"Galle","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000453397","article-title":"Cellular innate immunity: An old game with new players","volume":"9","author":"Gasteiger","year":"2017","journal-title":"J Innate Immun"},{"key":"10.1124\/pharmrev.121.000400_bib68","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fncel.2013.00045","article-title":"Origin and differentiation of microglia","volume":"7","author":"Ginhoux","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib70","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.18632\/aging.101518","article-title":"A promising connection between BDNF and Alzheimer\u2019s disease","volume":"10","author":"Giuffrida","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1124\/pharmrev.121.000400_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt233","article-title":"Open questions for Alzheimer\u2019s disease immunotherapy","volume":"6","author":"Golde","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1124\/pharmrev.121.000400_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cell.2011.04.018","article-title":"Estrogen receptor transrepresses brain inflammation","volume":"145","author":"Gosselin","year":"2011","journal-title":"Cell"},{"key":"10.1124\/pharmrev.121.000400_bib73","doi-asserted-by":"crossref","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","article-title":"An environment-dependent transcriptional network specifies human microglia identity","volume":"356","author":"Gosselin","year":"2017","journal-title":"Science"},{"key":"10.1124\/pharmrev.121.000400_bib74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0736-5748(00)00017-4","article-title":"Neuroprotective effects of estrogens: potential mechanisms of action","volume":"18","author":"Green","year":"2000","journal-title":"Int J Dev Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.dadm.2015.11.004","article-title":"MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer\u2019s disease","volume":"3","author":"Guedes","year":"2015","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1124\/pharmrev.121.000400_bib76","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s00018-017-2482-4","article-title":"Immunoregulatory properties of the cytokine IL-34","volume":"74","author":"Guillonneau","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pharmrev.121.000400_bib77","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.2063","article-title":"The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes","volume":"12","author":"Hanna","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib78","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-\u03b2 in a mouse model of Alzheimer\u2019s disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pharmrev.121.000400_bib79","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1523\/JNEUROSCI.0350-15.2016","article-title":"A\u03b240 reduces P-glycoprotein at the blood-brain barrier through the ubiquitin-proteasome pathway","volume":"36","author":"Hartz","year":"2016","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib80","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bpa.12159","article-title":"Failure of perivascular drainage of \u03b2-amyloid in cerebral amyloid angiopathy","volume":"24","author":"Hawkes","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1124\/pharmrev.121.000400_bib81","doi-asserted-by":"crossref","first-page":"29450","DOI":"10.1074\/jbc.M400950200","article-title":"Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages","volume":"279","author":"Hayashi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.121.000400_bib82","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/d41586-019-03892-8","article-title":"An immune-cell signature marks the brain in Alzheimer\u2019s disease","volume":"577","author":"Heneka","year":"2020","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000400_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1471-4159.2012.07887.x","article-title":"Modulation of interferon-\u03b3-induced glial cell activation by transforming growth factor B1: a role for STAT1 and MAPK pathways: modulation of glial cell activation by TGF\u03b21","volume":"123","author":"Herrera-Molina","year":"2012","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.121.000400_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1750-3639.2006.tb00560.x","article-title":"Mechanism of cerebral \u03b2-amyloid angiopathy: murine and cellular models","volume":"16","author":"Herzig","year":"2006","journal-title":"Brain Pathol"},{"key":"10.1124\/pharmrev.121.000400_bib85","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nn.3554","article-title":"The microglial sensome revealed by direct RNA sequencing","volume":"16","author":"Hickman","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib86","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cellimm.2018.01.001","article-title":"Fetal monocytes and the origins of tissue-resident macrophages","volume":"330","author":"Hoeffel","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib87","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1124\/pharmrev.121.000400_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000400_bib89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41232-016-0017-2","article-title":"Therapeutic intervention of inflammatory\/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway","volume":"36","author":"Imai","year":"2016","journal-title":"Inflamm Regen"},{"key":"10.1124\/pharmrev.121.000400_bib90","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1124\/pharmrev.121.000400_bib91","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-016-9960-9","article-title":"Friend or foe? Resident microglia vs bone marrow-derived microglia and their roles in the retinal degeneration","volume":"54","author":"Jin","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1124\/pharmrev.121.000400_bib92","doi-asserted-by":"crossref","first-page":"103641","DOI":"10.1016\/j.mcn.2021.103641","article-title":"Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer\u2019s disease","volume":"114","author":"Johannesson","year":"2021","journal-title":"Mol Cell Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib93","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni1569","article-title":"TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-\u03b2","volume":"9","author":"Kagan","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib94","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1533317512459798","article-title":"Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer\u2019s disease","volume":"27","author":"Kaiser","year":"2012","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1124\/pharmrev.121.000400_bib95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer\u2019s disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib96","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1182\/blood-2004-07-2972","article-title":"Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome","volume":"105","author":"Kanazawa","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pharmrev.121.000400_bib97","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid \u03b2-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.121.000400_bib98","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib99","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.24198","article-title":"STAT signaling in inflammation","volume":"2","author":"Kaplan","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1124\/pharmrev.121.000400_bib100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/intimm\/dxp017","article-title":"The roles of TLRs, RLRs and NLRs in pathogen recognition","volume":"21","author":"Kawai","year":"2009","journal-title":"Int Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib101","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3233\/JAD-170994","article-title":"Bone-marrow-derived microglia-like cells ameliorate brain amyloid pathology and cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"64","author":"Kawanishi","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.121.000400_bib102","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nn.3318","article-title":"Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways","volume":"16","author":"Kierdorf","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.403","article-title":"A postnatal peak in microglial development in the mouse hippocampus is correlated with heightened sensitivity to seizure triggers","volume":"5","author":"Kim","year":"2015","journal-title":"Brain Behav"},{"key":"10.1124\/pharmrev.121.000400_bib104","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2011.04.013","article-title":"The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes","volume":"34","author":"Kim","year":"2011","journal-title":"Immunity"},{"key":"10.1124\/pharmrev.121.000400_bib105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1124\/pharmrev.121.000400_bib106","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1523\/JNEUROSCI.2868-05.2005","article-title":"Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer\u2019s disease","volume":"25","author":"Kitazawa","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0092-8674(90)90219-5","article-title":"The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene","volume":"61","author":"Klemsz","year":"1990","journal-title":"Cell"},{"key":"10.1124\/pharmrev.121.000400_bib108","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1471-4159.2009.06521.x","article-title":"CREB-dependent Nur77 induction following depolarization in PC12 cells and neurons is modulated by MEF2 transcription factors","volume":"112","author":"Lam","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.121.000400_bib109","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","article-title":"\u03b2-Amyloid efflux mediated by p-glycoprotein","volume":"76","author":"Lam","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.121.000400_bib110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-065X.2008.00720.x","article-title":"DAP10- and DAP12-associated receptors in innate immunity","volume":"227","author":"Lanier","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1124\/pharmrev.121.000400_bib111","doi-asserted-by":"crossref","first-page":"23336","DOI":"10.1073\/pnas.1922788117","article-title":"CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages","volume":"117","author":"Lei","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib112","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020660118","article-title":"Reply to green and hume: nonmicroglia peripheral immune effects of short-term CSF1R inhibition with PLX5622","volume":"118","author":"Lei","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib113","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3389\/fimmu.2018.00698","article-title":"Microglia and beyond: innate immune cells as regulators of brain development and behavioral function","volume":"9","author":"Lenz","year":"2018","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib114","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.celrep.2017.08.009","article-title":"Triggering of NOD2 receptor converts inflammatory Ly6Chigh into Ly6Clow monocytes with patrolling properties","volume":"20","author":"Lessard","year":"2017","journal-title":"Cell Rep"},{"key":"10.1124\/pharmrev.121.000400_bib115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11011-014-9501-z","article-title":"Obesity as a risk factor for Alzheimer\u2019s disease: the role of adipocytokines","volume":"29","author":"Letra","year":"2014","journal-title":"Metab Brain Dis"},{"key":"10.1124\/pharmrev.121.000400_bib116","doi-asserted-by":"crossref","DOI":"10.1177\/1533317520927169","article-title":"Neuroprotective properties and therapeutic potential of bone marrow-derived microglia in Alzheimer\u2019s disease","volume":"35","author":"Li","year":"2020","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1124\/pharmrev.121.000400_bib117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"10.1124\/pharmrev.121.000400_bib118","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","article-title":"Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions","volume":"29","author":"Liu","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pharmrev.121.000400_bib119","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.2019000172","article-title":"Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD","volume":"134","author":"Liu","year":"2019","journal-title":"Blood"},{"key":"10.1124\/pharmrev.121.000400_bib120","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s11064-019-02817-1","article-title":"TREM2 attenuates A\u03b21-42-mediated neuroinflammation in BV-2 cells by downregulating TLR signaling","volume":"44","author":"Long","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1124\/pharmrev.121.000400_bib121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cellimm.2018.01.004","article-title":"Recent advances in the understanding of microglial development and homeostasis","volume":"330","author":"Low","year":"2018","journal-title":"Cell Immunol"},{"issue":"4","key":"10.1124\/pharmrev.121.000400_bib122","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.str.2012.02.010","article-title":"Structural basis for the dual recognition of helical cytokines IL-34 and CSF-1 by CSF-1R","volume":"20","author":"Ma","year":"2012","journal-title":"Structure (London, England: 1993)"},{"issue":"4","key":"10.1124\/pharmrev.121.000400_bib123","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1091\/mbc.e06-10-0975","article-title":"Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils","volume":"18","author":"Majumdar","year":"2007","journal-title":"Molecular Biology of the Cell"},{"key":"10.1124\/pharmrev.121.000400_bib28","doi-asserted-by":"crossref","first-page":"21198","DOI":"10.1073\/pnas.1914088116","article-title":"Amyloid-beta impairs TOM1-mediated IL-1R1 signaling","volume":"116","author":"Martini","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib124","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fncel.2020.00149","article-title":"Targeting microglial population dynamics in Alzheimer\u2019s disease: are we ready for a potential impact on immune function?","volume":"14","author":"Martin-Estebane","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ncl.2017.01.005","article-title":"Early-onset Alzheimer disease","volume":"35","author":"Mendez","year":"2017","journal-title":"Neurol Clin"},{"key":"10.1124\/pharmrev.121.000400_bib126","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1073\/pnas.1215165110","article-title":"Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer\u2019s disease-related pathology","volume":"110","author":"Michaud","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pharmrev.121.000400_bib127","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2005.08.047","article-title":"Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer\u2019s disease","volume":"391","author":"Minoretti","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1124\/pharmrev.121.000400_bib128","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.ajpath.2011.06.011","article-title":"Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-\u03b2 neurotoxicity","volume":"179","author":"Mizuno","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1124\/pharmrev.121.000400_bib129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.1100421","article-title":"The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood","volume":"188","author":"Mizutani","year":"2012","journal-title":"J Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1124\/pharmrev.121.000400_bib131","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/ene.13374","article-title":"Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer\u2019s disease","volume":"24","author":"Moonga","year":"2017","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1124\/pharmrev.121.000400_bib132","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-\u03b2 Peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1124\/pharmrev.121.000400_bib133","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","article-title":"Nonclassical monocytes in health and disease","volume":"37","author":"Narasimhan","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib134","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-015-0291-y","article-title":"Rodent models of neuroinflammation for Alzheimer\u2019s disease","volume":"12","author":"Nazem","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.121.000400_bib135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JIR.S137606","article-title":"NOD2 and inflammation: current insights","volume":"11","author":"Negroni","year":"2018","journal-title":"J Inflamm Res"},{"key":"10.1124\/pharmrev.121.000400_bib136","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41577-019-0141-8","article-title":"Heterogeneity of neutrophils","volume":"19","author":"Ng","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib137","doi-asserted-by":"crossref","DOI":"10.1177\/2398212819901082","article-title":"The Role of the Immune System in Driving Neuroinflammation","volume":"4","author":"N\u00ed Chasaide","year":"2020","journal-title":"Brain and Neuroscience Advances"},{"key":"10.1124\/pharmrev.121.000400_bib138","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease","volume":"411","author":"Ogura","year":"2001","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000400_bib139","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41467-018-02926-5","article-title":"A transcriptomic atlas of aged human microglia","volume":"9","author":"Olah","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/pharmrev.121.000400_bib140","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/pharmrev.121.000400_bib141","doi-asserted-by":"crossref","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","article-title":"Slow degradation of aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein by microglial cells","volume":"272","author":"Paresce","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.121.000400_bib142","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.4049\/jimmunol.178.4.2380","article-title":"RICK\/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs","volume":"178","author":"Park","year":"2007","journal-title":"J Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib143","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.cell.2013.11.030","article-title":"Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor","volume":"155","author":"Parkhurst","year":"2013","journal-title":"Cell"},{"key":"10.1124\/pharmrev.121.000400_bib144","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/cells9020383","article-title":"Impact of HMGB1, RAGE, and TLR4 in Alzheimer\u2019s disease (AD): from risk factors to therapeutic targeting","volume":"9","author":"Paudel","year":"2020","journal-title":"Cells"},{"key":"10.1124\/pharmrev.121.000400_bib145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3565","article-title":"NOD proteins: regulators of inflammation in health and disease","volume":"14","author":"Philpott","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib146","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2017.00211","article-title":"NETosis in Alzheimer\u2019s disease","volume":"8","author":"Pietronigro","year":"2017","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib147","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1111\/j.1460-9568.2012.08126.x","article-title":"The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer\u2019s disease","volume":"35","author":"Pimentel-Coelho","year":"2012","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib148","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fimmu.2020.00047","article-title":"Role of macrophage colony-stimulating factor receptor on the proliferation and survival of microglia following systemic nerve and cuprizone-induced injuries","volume":"11","author":"Pons","year":"2020","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib149","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-020-00747-7","article-title":"Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer\u2019s disease","volume":"13","author":"Pons","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.1124\/pharmrev.121.000400_bib150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fncel.2020.00284","article-title":"Beneficial roles of microglia and growth factors in MS, a brief review","volume":"14","author":"Pons","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib151","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2018.06.020","article-title":"Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer\u2019s disease-related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence","volume":"70","author":"Pourbadie","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1124\/pharmrev.121.000400_bib152","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ni.3703","article-title":"Ontogeny and homeostasis of CNS myeloid cells","volume":"18","author":"Prinz","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib153","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/glia.21104","article-title":"Microglia in the CNS: immigrants from another world","volume":"59","author":"Prinz","year":"2011","journal-title":"Glia"},{"issue":"9","key":"10.1124\/pharmrev.121.000400_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001713","article-title":"Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: A Mendelian randomization analysis","volume":"11","author":"Proitsi","year":"2014","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1124\/pharmrev.121.000400_bib155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-017-0091-7","article-title":"The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets","volume":"6","author":"Qi","year":"2017","journal-title":"Translational Neurodegeneration"},{"key":"10.1124\/pharmrev.121.000400_bib156","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/pharmrev.121.000400_bib157","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","article-title":"A polarizing question: do M1 and M2 microglia exist?","volume":"19","author":"Ransohoff","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib158","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-151183","article-title":"Monophosphoryl lipid-A: A promising tool for Alzheimer\u2019s disease toll","volume":"52","author":"Rego","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.121.000400_bib159","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/alz.12379","article-title":"Bayes analysis supports null hypothesis of anti-amyloid beta therapy in Alzheimer\u2019s disease","volume":"17","author":"Richard","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1124\/pharmrev.121.000400_bib160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/d41586-018-07165-8","article-title":"A \u2018don\u2019t eat me\u2019 immune signal protects neuronal connections","volume":"563","author":"Rivest","year":"2018","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000400_bib161","doi-asserted-by":"crossref","first-page":"639369","DOI":"10.3389\/fimmu.2021.639369","article-title":"Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer\u2019s Disease","volume":"12","author":"Rossi","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1124\/pharmrev.121.000400_bib162","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4103\/1673-5374.205084","article-title":"Neurotrophic factors in Alzheimer\u2019s and Parkinson\u2019s diseases: implications for pathogenesis and therapy","volume":"12","author":"Sampaio","year":"2017","journal-title":"Neural Regeneration Research"},{"key":"10.1124\/pharmrev.121.000400_bib163","doi-asserted-by":"crossref","first-page":"179.e17","DOI":"10.1016\/j.neurobiolaging.2018.01.015","article-title":"Mendelian adult-onset leukodystrophy genes in Alzheimer\u2019s disease: critical influence of CSF1R and NOTCH3","volume":"66","author":"Sassi","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1124\/pharmrev.121.000400_bib164","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/neup.12235","article-title":"TMEM119 marks a subset of microglia in the human brain: human microglial marker TMEM119","volume":"36","author":"Satoh","year":"2016","journal-title":"Neuropathology"},{"key":"10.1124\/pharmrev.121.000400_bib165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","article-title":"The cholinergic system in aging and neuronal degeneration","volume":"221","author":"Schliebs","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1124\/pharmrev.121.000400_bib166","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI31450","article-title":"Sustained hippocampal IL-1 \u03b2 overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology","volume":"117","author":"Shaftel","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.121.000400_bib2","article-title":"Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity","author":"Shaona","year":"2018","journal-title":"The Journal of Neuroscience"},{"key":"10.1124\/pharmrev.121.000400_bib167","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0969-9961(03)00069-X","article-title":"Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid \u03b2 peptide in APPswe transgenic mice","volume":"14","author":"Sheng","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1124\/pharmrev.121.000400_bib168","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1124\/pharmrev.121.000400_bib169","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1194\/jlr.R075796","article-title":"Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: evidence from clinical and preclinical studies","volume":"58","author":"Shinohara","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1124\/pharmrev.121.000400_bib170","doi-asserted-by":"crossref","first-page":"7905486","DOI":"10.1155\/2017\/7905486","article-title":"P-glycoprotein (ABCB1) and oxidative stress: focus on Alzheimer\u2019s disease","volume":"2017","author":"Sita","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1124\/pharmrev.121.000400_bib171","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-8-92","article-title":"TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"8","author":"Song","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.121.000400_bib172","doi-asserted-by":"crossref","first-page":"1475435","DOI":"10.1155\/2016\/1475435","article-title":"Monocyte heterogeneity: consequences for monocyte-derived immune cells","volume":"2016","author":"Sprangers","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1124\/pharmrev.121.000400_bib173","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1124\/pharmrev.121.000400_bib174","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b2(1-42) across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.121.000400_bib175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fnmol.2017.00319","article-title":"Alzheimer\u2019s disease: from genetic variants to the distinct pathological mechanisms","volume":"10","author":"Sun","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib176","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/glia.22421","article-title":"Complex invasion pattern of the cerebral cortex bymicroglial cells during development of the mouse embryo","volume":"61","author":"Swinnen","year":"2013","journal-title":"Glia"},{"key":"10.1124\/pharmrev.121.000400_bib177","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fncel.2018.00323","article-title":"Bidirectional microglia-neuron communication in health and disease","volume":"12","author":"Szepesi","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib178","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/brain\/awl249","article-title":"Role of toll-like receptor signalling in Abeta uptake and clearance","volume":"129","author":"Tahara","year":"2006","journal-title":"Brain"},{"key":"10.1124\/pharmrev.121.000400_bib179","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2443.2006.00988.x","article-title":"TGF-beta1 suppresses IFN-\u03b3-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation","volume":"11","author":"Takaki","year":"2006","journal-title":"Genes Cells"},{"key":"10.1124\/pharmrev.121.000400_bib180","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1124\/pharmrev.121.000400_bib181","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2008.01.061","article-title":"Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling","volume":"368","author":"Tanimura","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pharmrev.121.000400_bib182","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/intimm\/dxt071","article-title":"The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4\/MD2 complex at the plasma membrane","volume":"26","author":"Tanimura","year":"2014","journal-title":"Int Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib183","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1742-2094-8-187","article-title":"Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K\/Akt pathway","volume":"8","author":"Tarassishin","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1124\/pharmrev.121.000400_bib184","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","article-title":"Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis\/lipohyalinosis with cognitive decline","volume":"62","author":"Thal","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1124\/pharmrev.121.000400_bib185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13195-015-0125-2","article-title":"The dynamics of monocytes and microglia in Alzheimer\u2019s disease","volume":"7","author":"Th\u00e9riault","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.1124\/pharmrev.121.000400_bib186","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/ATVBAHA.114.304650","article-title":"Nonclassical patrolling monocyte function in the vasculature","volume":"35","author":"Thomas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pharmrev.121.000400_bib187","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","article-title":"Blocking TGF-\u03b2-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology","volume":"14","author":"Town","year":"2008","journal-title":"Nat Med"},{"key":"10.1124\/pharmrev.121.000400_bib188","doi-asserted-by":"crossref","first-page":"n1682","DOI":"10.1136\/bmj.n1682","article-title":"Aducanumab for Alzheimer\u2019s disease?","volume":"374","author":"Walsh","year":"2021","journal-title":"BMJ"},{"key":"10.1124\/pharmrev.121.000400_bib189","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000110455","article-title":"Role of the toll-like receptor 4 in neuroinflammation in Alzheimer\u2019s disease","volume":"20","author":"Walter","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1124\/pharmrev.121.000400_bib190","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1124\/pharmrev.121.000400_bib191","doi-asserted-by":"crossref","first-page":"577823","DOI":"10.3389\/fimmu.2020.577823","article-title":"MPL adjuvant contains competitive antagonists of human TLR4","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib192","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1212\/WNL.0000000000000382","article-title":"Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy","volume":"82","author":"Westwood","year":"2014","journal-title":"Neurology"},{"key":"10.1124\/pharmrev.121.000400_bib193","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3233\/JAD-2012-120763","article-title":"The effects of ramipril in individuals at risk for Alzheimer\u2019s disease: results of a pilot clinical trial","volume":"32","author":"Wharton","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1124\/pharmrev.121.000400_bib194","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.15252\/embj.201696056","article-title":"A novel microglial subset plays a key role in myelinogenesis in developing brain","volume":"36","author":"Wlodarczyk","year":"2017","journal-title":"EMBO J"},{"key":"10.1124\/pharmrev.121.000400_bib195","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3389\/fimmu.2019.01642","article-title":"The ontogeny of monocyte subsets","volume":"10","author":"Wolf","year":"2019","journal-title":"Front Immunol"},{"key":"10.1124\/pharmrev.121.000400_bib196","doi-asserted-by":"crossref","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1124\/pharmrev.121.000400_bib197","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MOH.0000000000000196","article-title":"Interferon regulatory factor 8 and the regulation of neutrophil, monocyte, and dendritic cell production","volume":"23","author":"Y\u00e1\u00f1ez","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1124\/pharmrev.121.000400_bib198","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1016\/S0021-9258(18)52990-2","article-title":"Transcriptional activation of the inducible nuclear receptor gene nur77 by nerve growth factor and membrane depolarization in PC12 cells","volume":"268","author":"Yoon","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/pharmrev.121.000400_bib199","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12031-018-1249-1","article-title":"Prestimulation of microglia through TLR4 pathway promotes interferon beta expression in a rat model of Alzheimer\u2019s disease","volume":"67","author":"Yousefi","year":"2019","journal-title":"J Mol Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamaneurol.2014.3049","article-title":"Association of brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease","volume":"72","author":"Yu","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1124\/pharmrev.121.000400_bib201","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12035-019-01697-4","article-title":"Origins of beta amyloid differ between vascular amyloid deposition and parenchymal amyloid plaques in the spinal cord of a mouse model of Alzheimer\u2019s disease","volume":"57","author":"Yuan","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1124\/pharmrev.121.000400_bib202","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnagi.2018.00042","article-title":"Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer\u2019s disease brain: a review","volume":"10","author":"Zhan","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1124\/pharmrev.121.000400_bib203","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","article-title":"Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci Rep"},{"key":"10.1124\/pharmrev.121.000400_bib204","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.13111","article-title":"TGF\u03b21 inhibits IFN\u03b3-mediated microglia activation and protects mDA neurons from IFN\u03b3-driven neurotoxicity","volume":"134","author":"Zhou","year":"2015","journal-title":"J Neurochem"},{"key":"10.1124\/pharmrev.121.000400_bib205","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40478-016-0405-5","article-title":"Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade","volume":"5","author":"Zhu","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.1124\/pharmrev.121.000400_bib206","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/ATVBAHA.116.304054","article-title":"2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development","volume":"36","author":"Zhu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pharmrev.121.000400_bib207","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"},{"key":"10.1124\/pharmrev.121.000400_bib208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clinbiochem.2019.04.015","article-title":"Clinical aspects of Alzheimer\u2019s disease","volume":"72","author":"Zv\u011b\u0159ov\u00e1","year":"2019","journal-title":"Clin Biochem"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724007099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pharmrev.121.000400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T12:20:40Z","timestamp":1740054040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724007099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":208,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0031699724007099"],"URL":"https:\/\/doi.org\/10.1124\/pharmrev.121.000400","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pharmrev.121.000400","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}